Steering brain stimulation could ease Parkinson's symptoms

NCT ID NCT03548506

First seen Jun 08, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This study tested two types of deep brain stimulation in 20 people with Parkinson's disease: standard omnidirectional stimulation and a newer directional steering method. The goal was to see if steering the stimulation could better control motor symptoms like muscle rigidity. Participants received both types in a randomized, double-blind crossover design, and the researchers measured effects using muscle activity and clinical rating scales.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University Hospital Tuebingen, Dep. of Neurosurgery (Functional Neurosurgery) and Neurology (Neurodegenerative Diseases)

    Tübingen, Baden-Wurttemberg, 72076, Germany

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Deep brain stimulation device

What this could lead to

If successful, this could lead to more precise deep brain stimulation that better controls Parkinson's motor symptoms with fewer side effects.

What could go wrong

This is a small, early-stage study with only 20 participants, so results may not apply to all Parkinson's patients. The benefits of directional stimulation over standard stimulation are still uncertain.

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.